Casabronstein méier resultado

Kaplan-Meier analysis of clinical outcomes in critical COVID-19

Por um escritor misterioso
Last updated 09 novembro 2024
Kaplan-Meier analysis of clinical outcomes in critical COVID-19
Kaplan-Meier analysis of clinical outcomes in critical COVID-19
Tocilizumab improves 28-day survival in hospitalized patients with
Kaplan-Meier analysis of clinical outcomes in critical COVID-19
Learning accurate personalized survival models for predicting
Kaplan-Meier analysis of clinical outcomes in critical COVID-19
Full article: Effect of Aspirin Use on clinical Outcome among
Kaplan-Meier analysis of clinical outcomes in critical COVID-19
Prevalence, characteristics, and longer-term outcomes of patients
Kaplan-Meier analysis of clinical outcomes in critical COVID-19
JCM, Free Full-Text
Kaplan-Meier analysis of clinical outcomes in critical COVID-19
Clinical use of remdesivir in COVID-19 treatment: a retrospective
Kaplan-Meier analysis of clinical outcomes in critical COVID-19
Epidemiology, clinical course, and outcomes of critically ill
Kaplan-Meier analysis of clinical outcomes in critical COVID-19
Effect of hypertension on outcomes of adult inpatients with COVID
Kaplan-Meier analysis of clinical outcomes in critical COVID-19
Clinical outcomes and survival analysis. (a) Clinical outcomes of
Kaplan-Meier analysis of clinical outcomes in critical COVID-19
Use of proton pump inhibitors are associated with higher mortality
Kaplan-Meier analysis of clinical outcomes in critical COVID-19
Ascorbic acid as an adjunctive therapy in critically ill patients
Recomendado para você
você pode gostar

© 2014-2024 progresstn.com. All rights reserved.